Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study
Campochiaro et al., European Journal of Internal Medicine, doi:10.1016/j.ejim.2020.05.021
https://c19early.org/campochiaro.html